![](https://capedge.com/proxy/8-K/0001264931-15-000037/image_001.jpg)
Exhibit 99.1
January 26, 2015
ClearTrust, LLC is Immune Therapeutics’
New Transfer Agent and Support Provider
No Action Required of Shareholders for this Transaction
Dear Immune Therapeutics, Inc. Shareholder:
I am writing today to update you on an important operational change. ClearTrust, LLC, a leading stock transfer agent serving growth companies and community banks, has acquired all issuer accounts of Guardian Registrar & Transfer, Inc., our transfer agent. As a result, ClearTrust is now Immune Therapeutics’ transfer agent and shareholder support provider.
This change includes the transfer of your directly held shares of Immune Therapeutics’ common stock from Guardian Registrar & Transfer to ClearTrust’s platform.There is no action required on your part for this transaction.
If you have any questions regarding your shares, please contact a ClearTrust specialist by telephone at (813) 235-4490 or email at inbox@ClearTrustTransfer.com. If you need to send documents to ClearTrust, such documents can be emailed to the foregoing email address, faxed to (813) 388-4549 or mailed to 16540 Pointe Village Drive, Suite 210, Lutz, Florida 33558.
Thank you for your continued support of Immune Therapeutics.
| | Sincerely, |
| | |
| | |
| | Noreen Griffin |
| | Chief Executive Officer |
37 North Orange Ave, Suite 607, Orlando, FL 32801
(888) 613-8802 Fax: (866) 514-8807
www.immunetherapeutics.com